X4 PHARMACEUTICALS INC (XFOR:NASDAQ)
$3.12 -0.13 (-4%)
Analysed X4 PHARMACEUTICALS INC (XFOR:NASDAQ) News Sources
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07-07-2026
yahoo.com
X4 Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
06-08-2026
yahoo.com
X4 Pharmaceuticals (XFOR) Reports Q2 Loss, Beats Revenue Estimates
06-08-2026
yahoo.com
X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting
08-09-2026
yahoo.com
X4 Pharmaceuticals (XFOR) Loses 20.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11-09-2026
yahoo.com
Down 25.4% in 4 Weeks, Here's Why X4 Pharmaceuticals (XFOR) Looks Ripe for a Turnaround
24-09-2026
yahoo.com
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01-10-2026
yahoo.com
X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
08-10-2026
yahoo.com
X4 Pharmaceuticals Secures Up to $150 Million in New Debt Financing From K2 HealthVentures
08-10-2026
advfn.com
X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders
09-10-2026
yahoo.com
What is the current price of X4 PHARMACEUTICALS INC (XFOR:NASDAQ)?
The current price of X4 PHARMACEUTICALS INC (XFOR:NASDAQ) is $3.12.
X4 PHARMACEUTICALS INC (XFOR:NASDAQ) absolute price change since previous trading day?
The absolute price change of X4 PHARMACEUTICALS INC (XFOR:NASDAQ) since the previous trading day is $-0.13.
X4 PHARMACEUTICALS INC (XFOR:NASDAQ) percentage price change since previous trading day?
The percentage price change of X4 PHARMACEUTICALS INC (XFOR:NASDAQ) since the previous trading day is -4%.
What is the most recent average sentiment score for X4 PHARMACEUTICALS INC (XFOR:NASDAQ)?
The most recent average sentiment score for X4 PHARMACEUTICALS INC (XFOR:NASDAQ) is 58 out of 100.
What is the most recent average sentiment for X4 PHARMACEUTICALS INC (XFOR:NASDAQ)?
The most recent sentiment for X4 PHARMACEUTICALS INC (XFOR:NASDAQ) is .
SEC-8K** Filing Available For X4 PHARMACEUTICALS INC (XFOR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.